Literature DB >> 15800034

Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998.

Lois Swirsky Gold1, Neela B Manley, Thomas H Slone, Lars Rohrbach, Georganne Backman Garfinkel.   

Abstract

The Carcinogenic Potency Database (CPDB) is a systematic and unifying resource that standardizes the results of chronic, long-term animal cancer tests which have been conducted since the 1950s. The analyses include sufficient information on each experiment to permit research into many areas of carcinogenesis. Both qualitative and quantitative information is reported on positive and negative experiments that meet a set of inclusion criteria. A measure of carcinogenic potency, TD(50) (daily dose rate in mg/kg body weight/day to induce tumors in half of test animals that would have remained tumor-free at zero dose), is estimated for each tissue-tumor combination reported. This article is the ninth publication of a chronological plot of the CPDB; it presents results on 560 experiments of 188 chemicals in mice, rats, and hamsters from 185 publications in the general literature updated through 1997, and from 15 Reports of the National Toxicology Program in 1997-1998. The test agents cover a wide variety of uses and chemical classes. The CPDB Web Site (http://potency.berkeley.edu/) presents the combined database of all published plots in a variety of formats as well as summary tables by chemical and by target organ, supplemental materials on dosing and survival, a detailed guide to using the plot formats, and documentation of methods and publications. The overall CPDB, including the results in this article, presents easily accessible results of 6153 experiments on 1485 chemicals from 1426 papers and 429 NCI/NTP (National Cancer Institute/National Toxicology program) Technical Reports. A tab-separated format of the full CPDB for reading the data into spreadsheets or database applications is available on the Web Site.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800034     DOI: 10.1093/toxsci/kfi161

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  18 in total

1.  A Set of Six Gene Expression Biomarkers Identify Rat Liver Tumorigens in Short-term Assays.

Authors:  J Christopher Corton; Thomas Hill; Jeffrey J Sutherland; James L Stevens; John Rooney
Journal:  Toxicol Sci       Date:  2020-09-01       Impact factor: 4.849

Review 2.  Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators.

Authors:  Brian G Lake
Journal:  Toxicol Res (Camb)       Date:  2018-03-12       Impact factor: 3.524

Review 3.  Genetic toxicology in the 21st century: reflections and future directions.

Authors:  Brinda Mahadevan; Ronald D Snyder; Michael D Waters; R Daniel Benz; Raymond A Kemper; Raymond R Tice; Ann M Richard
Journal:  Environ Mol Mutagen       Date:  2011-04-28       Impact factor: 3.216

4.  GFP-fused yeast cells as whole-cell biosensors for genotoxicity evaluation of nitrosamines.

Authors:  Ying He; Haotian Ding; Xingya Xia; Wenyi Qi; Huaisong Wang; Wenyuan Liu; Feng Zheng
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-06       Impact factor: 4.813

5.  Screening of potential targets in Plasmodium falciparum using stage-specific metabolic network analysis.

Authors:  Neel Dholakia; Pinakin Dhandhukia; Nilanjan Roy
Journal:  Mol Divers       Date:  2015-08-25       Impact factor: 2.943

Review 6.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

7.  Structure-activity relationship models for rat carcinogenesis and assessing the role mutagens play in model predictivity.

Authors:  C A Carrasquer; K Batey; S Qamar; A R Cunningham; S L Cunningham
Journal:  SAR QSAR Environ Res       Date:  2014-04-04       Impact factor: 3.000

8.  Successful drug development despite adverse preclinical findings part 2: examples.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; Makoto Hayashi; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

Review 9.  A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.

Authors:  Kathryn Z Guyton; Weihsueh A Chiu; Thomas F Bateson; Jennifer Jinot; Cheryl Siegel Scott; Rebecca C Brown; Jane C Caldwell
Journal:  Environ Health Perspect       Date:  2009-05-15       Impact factor: 9.031

10.  Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice.

Authors:  Marcel Leist; Thomas Hartung
Journal:  Arch Toxicol       Date:  2013-03-19       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.